Date:  10/31/2006

Time:   Breakfast & Registration: 7:30 a.m. Program: 8:00 a.m. – 9:30 a.m.

Location:   Morrison & Foerster LLP 12531 High Bluff Drive, Suite 100 San Diego, California

Speakers:   Mark R. Wicker, Michael B. Miller, W. Stephen Smith, Christopher Norall

Contact Email:   sdmarketing@mofo.com

Description:  

The Limits of Cooperation: Life Sciences Companies Face New Antitrust Constraints

Few sectors of the U.S. and global economy receive as much antitrust scrutiny as the life sciences industry. A confluence of industry trends and a generally difficult regulatory and political environment suggest that life sciences companies may soon experience even greater public and regulatory attention. Join us to learn how you can protect your company from government challenges that may slow down or halt the execution of your business strategies.

Topics will include:

• Government and Private Enforcement ‑ antitrust challenges to patent litigation settlement agreements; scrutiny of authorized generic products and bio-generics
• IP Licensing ‑ how antitrust enforcement agencies and private plaintiffs worldwide are increasingly questioning whether certain provisions in IP licenses run afoul of the antitrust laws
• Strategic Alliances ‑ increasing antitrust scrutiny of mergers and acquisitions involving biologic products; antitrust issues arising from joint control and information exchange
• EU Regulation ‑ how the maze of new regulations applies to cooperation agreements; recent cases dealing with marketing of generics and with parallel trade issues between EU Member States

Who Should Attend

In-house counsel, CEOs, CFOs, and other senior management in the life sciences industry

MCLE Accredited

Morrison & Foerster LLP (provider # 2183) certifies that this activity has been approved for MCLE credit by the State Bar of California in the amount of 1.5 hours.